Understanding Fentanyl Citrate Injection Formulations in the UK: A Clinical Overview
Fentanyl citrate remains one of the most vital tools in modern-day anaesthesia and sharp pain management across the United Kingdom. As a potent synthetic opioid, its function in the National Health Service (NHS) and personal surgical sectors is well-established, mainly due to its fast onset of action and cardiovascular stability. This article supplies an extensive introduction of fentanyl citrate injection formulations readily available in the UK, their clinical signs, regulatory landscape, and administration procedures.
What is Fentanyl Citrate?
Fentanyl citrate is a potent phenylpiperidine-derivative opioid agonist. It was first synthesized in 1960 and rapidly became a foundation of perioperative care. In terms of potency, fentanyl is approximately 50 to 100 times more powerful than morphine. Its high lipophilicity allows it to cross the blood-brain barrier quickly, resulting in a practically instant analgesic result when administered intravenously.
In the UK, fentanyl citrate is mainly utilized through the parenteral path (injection) for both sedative and analgesic purposes. It works primarily by binding to the mu-opioid receptors in the central nervous system, altering the understanding of discomfort and the emotional action to it.
Medical Indications in the UK
According to the British National Formulary (BNF), fentanyl citrate injection is shown for a number of specific medical situations:
- Analgesic Action: Used throughout brief operative treatments and in the healing room.
- Analgesic Supplement: Used during the induction and maintenance of inhalation anaesthesia.
- Neuroleptanalgesia: Often utilized in mix with a neuroleptic (such as droperidol) to accomplish a state of quiescence and minimized awareness.
- Management of Severe Pain: Particularly in the Intensive Care Unit (ICU) for patients on mechanical ventilation.
- Pre-medication: To provide sedation and analgesia before the induction of general anaesthesia.
Offered Formulations and Strengths in the UK
The UK market offers several solutions of fentanyl citrate, designed to satisfy the varying needs of surgical and emergency departments. These are generally presented as clear, colourless services for injection or infusion.
Table 1: Common Fentanyl Citrate Formulations in the UK
| Strength (Fentanyl base) | Presentation | Typical Packaging | Maker Examples |
|---|---|---|---|
| 50 micrograms/ml | 2 ml Ampoule | Pack of 10 | Hameln, Advanz Pharma |
| 50 micrograms/ml | 10 ml Ampoule | Load of 5 or 10 | Hameln, Wockhardt |
| 50 micrograms/ml | 20 ml Vial/Ampoule | Load of 5 | Hameln, Generic |
| 50 micrograms/ml | 50 ml Vial | Individual/Pack of 1 | Generic (ICU usage) |
Note: While 50 mcg/ml is the standard concentration, specialised solutions for epidural or intrathecal use may in some cases be prepared by health center pharmacies under particular procedures.
Pharmacokinetics and Pharmacodynamics
Comprehending how the body processes fentanyl is vital for safe administration.
- Onset of Action: When administered intravenously, the result begins almost right away, though the maximal analgesic effect might take 3 to 5 minutes.
- Period: A single intravenous dose of 100 micrograms normally lasts for 30 to 60 minutes.
- Metabolism: Fentanyl is mainly metabolised in the liver through the CYP3A4 enzyme system.
- Excretion: Approximately 75% of the dose is excreted in the urine within 24 hours, mainly as metabolites.
Administration Protocols
In the UK, the administration of fentanyl citrate is strictly controlled and usually performed by anaesthetists or trained professionals in regulated environments.
Dosage Guidelines
Dose must be horizontal and individualised based upon the client's age, weight, physical status, underlying pathological condition, use of other drugs, and the type of surgical treatment.
- Low Dose (2 mcg/kg): Useful for minor surgical treatments.
- Moderate Dose (2-- 20 mcg/kg): Used when surgical treatment is more invasive; requires respiratory tracking.
- High Dose (20-- 50 mcg/kg): Used during "stress-free" significant surgical treatments (e.g., open-heart surgery) to safeguard the myocardium from the metabolic needs of tension.
Paths of Administration
- Intravenous (IV) Bolus: Common for induction.
- Intravenous Infusion: Used for longer procedures or in the ICU.
- Intramuscular (IM): Less common, however used for pre-medication in specific situations.
Regulatory Status and Safety
In the United Kingdom, Fentanyl is classified under the Misuse of Drugs Act 1971 as a Class A drug. Under the Misuse of Drugs Regulations 2001, it is categorized as a Schedule 2 Controlled Drug (CD POM).
Statutory Requirements for UK Hospitals:
- Safe Custody: Must be kept in a locked controlled drug cabinet.
- Record Keeping: Every administration must be tape-recorded in a Controlled Drugs Register (CDR).
- Destruction: Surplus or ended fentanyl should be denatured and experienced by authorised workers.
Negative Effects and Adverse Reactions
While highly effective, fentanyl citrate carries a risk of substantial adverse effects.
- Breathing Depression: The most serious side effect, which can result in respiratory arrest if not kept an eye on.
- Bradychardia: Often handled with atropine.
- Muscle Rigidity (Chest Wall Rigidity): High dosages can make ventilation hard, needing making use of neuromuscular blocking representatives.
- Queasiness and Vomiting: Common in the postoperative period.
- Hypotension: Although more stable than morphine, it can still occur, specifically in hypovolaemic clients.
Contrast with Other Opioids
Clinicians typically select fentanyl over other opioids due to its particular pharmacokinetic profile.
Table 2: Comparison of Parenteral Opioids in UK Practice
| Function | Fentanyl | Morphine | Remifentanil |
|---|---|---|---|
| Relative Potency | 100 | 1 | 100-200 |
| Start | 1-- 3 minutes | 15-- 30 minutes | 1 minute |
| Period of Action | 30-- 60 minutes | 3-- 4 hours | 5-- 10 minutes |
| Histamine Release | Minimal | Substantial | Minimal |
| Primary Use | Intraoperative/ICU | Post-operative/Chronic | Titratable Infusion |
Frequently Asked Questions (FAQ)
1. Is fentanyl citrate injection the like the fentanyl spots?
No. While they consist of the very same active drug, the injection is for instant, acute usage in surgical or emergency situation settings. Patches (transdermal delivery) are created for chronic, long-lasting discomfort management and release the medication slowly over 72 hours.
2. Fentanyl Citrate Injection Formulations UK be utilized for kids in the UK?
Yes, it is frequently utilized in paediatric anaesthesia. However, the dose should be strictly computed based upon the kid's weight, and they need to be monitored carefully for respiratory depression.
3. What is the antagonist for fentanyl?
Naloxone is the specific pharmacological antagonist used to reverse the effects of fentanyl, including breathing anxiety. In UK medical facilities, naloxone needs to always be easily available wherever fentanyl is administered.
4. Why is it used over morphine in heart surgery?
Fentanyl is chosen in heart surgical treatment since it does not cause the release of histamine, which can cause vasodilation and hypotension. It supplies cardiovascular stability even at high doses.
5. What are the storage requirements?
Fentanyl citrate injection must be kept listed below 25 ° C and secured from light. As a Schedule 2 drug, it should be kept in a lawfully compliant CD cabinet.
Fentanyl citrate injection formulas are vital parts of the UK's medical toolkit for handling perioperative discomfort and facilitating complex surgeries. Its high strength and fast beginning deal unrivaled precision for anaesthetists, provided that strenuous tracking and regulatory requirements are preserved. By comprehending the numerous concentrations and the rigorous procedures surrounding its use, healthcare experts make sure that this effective medication stays both safe and effective for clients across the nation.
Disclaimer: This article is for educational functions only and does not constitute medical suggestions. Health care professionals ought to constantly describe the Summary of Product Characteristics (SmPC) and existing BNF guidelines for the most current recommending info.
